Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.

Kevin M Slawin, Shahrokh Shariat, Eduardo Canto

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary

    Benign prostate-specific antigen (BPSA) is a novel form of free PSA (fPSA) linked to prostate enlargement. BPSA levels correlate better with transition zone volume than PSA or fPSA, aiding in predicting prostate enlargement independent of age.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials.

    European urology oncology·2026
    Same author

    Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

    Journal of the National Comprehensive Cancer Network : JNCCN·2026
    Same author

    Pathological assessment of morcellated tissue after ERBT: insights from a two-round Delphi survey.

    World journal of urology·2026
    Same author

    Training and external validation of machine learning supervised prognostic models of upper tract urothelial cancer (UTUC) after nephroureterectomy.

    Scientific reports·2026
    Same author

    Pathology of the upper urinary tract tumours: Histologic subtypes, genetics, biomarker testing.

    Histopathology·2025
    Same author

    Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study.

    World journal of urology·2025

    Area of Science:

    • Urology
    • Biochemistry
    • Oncology

    Background:

    • Free prostate-specific antigen (fPSA) testing is widely used for prostate cancer screening, but its biological basis for differentiating benign prostatic hyperplasia (BPH) from cancer is not fully understood.
    • The relationship between total PSA and prostate volume was hypothesized to be primarily influenced by the fPSA component.

    Purpose of the Study:

    • To investigate the molecular forms of PSA in prostate tissue.
    • To discover and characterize novel PSA forms related to benign prostatic conditions.
    • To evaluate the utility of BPSA in assessing prostate volume and predicting prostate enlargement.

    Main Methods:

    • Analysis of molecular forms of PSA in prostate tissue.
    • Discovery and characterization of benign PSA (BPSA).

    Related Experiment Videos

  • Correlation studies between serum BPSA levels and transition zone (TZ) and total prostate volume.
  • Comparison of BPSA, PSA, and fPSA in predicting prostate enlargement.

    • Main Results:

    • A novel form of fPSA, termed benign PSA (BPSA), was discovered, associated with nodular hyperplasia of the transition zone (TZ).
    • Serum BPSA levels showed a strong correlation with TZ and total prostate volume.
    • BPSA demonstrated a stronger correlation with TZ volume compared to total PSA or fPSA.
    • BPSA proved to be a better predictor of clinically significant prostate enlargement than PSA or fPSA.
    • The association of BPSA and fPSA with prostate volumes was independent of patient age.

    Conclusions:

    • BPSA is a significant molecular form of fPSA primarily associated with benign prostatic hyperplasia in the transition zone.
    • Serum BPSA levels are a more accurate indicator of transition zone volume and potential prostate enlargement than traditional PSA or fPSA measurements.
    • BPSA offers a promising biomarker for predicting prostate enlargement, independent of age, potentially improving diagnostic and management strategies in urology.